| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
63,149 |
56,325 |
$2.21M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,322 |
7,970 |
$613K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,083 |
6,816 |
$546K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12,909 |
11,980 |
$535K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
12,542 |
11,506 |
$503K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
37,923 |
17,756 |
$497K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,217 |
5,734 |
$483K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,986 |
5,573 |
$431K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
33,053 |
14,788 |
$341K |
| S8301 |
Infection control supplies, not otherwise specified |
47,740 |
42,135 |
$329K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,450 |
4,136 |
$222K |
| 99429 |
|
7,034 |
6,815 |
$221K |
| 87428 |
|
3,087 |
2,948 |
$205K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,945 |
8,576 |
$119K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,679 |
1,591 |
$97K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,703 |
3,508 |
$84K |
| 87634 |
|
1,298 |
1,247 |
$75K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,354 |
5,167 |
$56K |
| 90461 |
|
6,033 |
4,751 |
$41K |
| 99000 |
|
3,941 |
3,820 |
$38K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,233 |
1,196 |
$37K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,710 |
2,562 |
$35K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,236 |
1,197 |
$33K |
| 87807 |
|
2,297 |
2,083 |
$24K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,050 |
1,918 |
$19K |
| CP002 |
|
1,842 |
1,641 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
427 |
401 |
$17K |
| 99051 |
|
2,413 |
2,248 |
$15K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
161 |
158 |
$12K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
813 |
754 |
$12K |
| 86318 |
|
720 |
692 |
$11K |
| 96161 |
|
6,043 |
5,805 |
$11K |
| 90473 |
|
1,281 |
1,270 |
$10K |
| 92567 |
|
729 |
708 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,438 |
1,344 |
$9K |
| 81002 |
|
3,064 |
2,919 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
623 |
530 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
487 |
470 |
$6K |
| 90474 |
|
543 |
530 |
$4K |
| 97169 |
|
162 |
150 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
26 |
26 |
$2K |
| 99050 |
|
114 |
113 |
$2K |
| 96381 |
|
71 |
69 |
$1K |
| 90619 |
|
1,138 |
1,080 |
$544.11 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
371 |
306 |
$540.33 |
| 81025 |
|
53 |
51 |
$368.73 |
| 90620 |
|
991 |
958 |
$256.20 |
| 86580 |
|
30 |
30 |
$247.56 |
| 90686 |
|
1,804 |
1,771 |
$86.69 |
| 90671 |
|
1,000 |
950 |
$82.00 |
| 90651 |
|
2,170 |
2,078 |
$78.00 |
| 86308 |
|
13 |
13 |
$56.55 |
| 97802 |
|
14,995 |
14,420 |
$15.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
16 |
$9.12 |
| 83655 |
|
341 |
333 |
$3.35 |
| 90670 |
|
3,650 |
3,580 |
$2.00 |
| 96160 |
|
1,183 |
1,086 |
$2.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
15,024 |
14,413 |
$1.17 |
| 90677 |
|
16 |
16 |
$1.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
79 |
78 |
$0.50 |
| 90696 |
|
606 |
580 |
$0.35 |
| 90697 |
|
66 |
66 |
$0.35 |
| 90680 |
|
2,590 |
2,513 |
$0.00 |
| 90723 |
|
3,445 |
3,351 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
1,121 |
1,085 |
$0.00 |
| 90660 |
|
3,271 |
3,185 |
$0.00 |
| 90656 |
|
404 |
400 |
$0.00 |
| 90381 |
|
56 |
54 |
$0.00 |
| 90648 |
|
4,589 |
4,457 |
$0.00 |
| 90710 |
|
2,158 |
2,092 |
$0.00 |
| 90700 |
|
622 |
609 |
$0.00 |
| 90633 |
|
2,237 |
2,180 |
$0.00 |
| 90715 |
|
515 |
490 |
$0.00 |
| 90734 |
|
349 |
331 |
$0.00 |
| 99072 |
|
12 |
12 |
$0.00 |